GlycoMimetics, Inc. (GLYC)

GlycoMimetics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-36.9	-46.69	-63.43	-51.03	-57.89
Depreciation & Amortization	1.01	1.03	1.01	0.95	0.9
Share-Based Compensation	3.56	3.86	6.09	6.9	6.22
Other Operating Activities	-2.55	-4.66	-1.16	3.93	-1.21
Operating Cash Flow	-34.88	-46.46	-57.49	-39.24	-51.98
Capital Expenditures	-0.02	-0.08	-0.01	-0.07	-0.14
Investing Cash Flow	-0.02	-0.08	-0.01	-0.07	-0.14
Share Issuance / Repurchase	28.82	4.16	10.72	18.14	0.41
Financing Cash Flow	28.82	4.16	10.72	18.14	0.41
Net Cash Flow	-6.08	-42.38	-46.78	-21.17	-51.72
Free Cash Flow	-34.9	-46.54	-57.5	-39.31	-52.13
Free Cash Flow Margin	-349012.97%	-62055.57%	-4958.28%	-386.80%	-
Free Cash Flow Per Share	-0.55	-0.89	-1.12	-0.86	-1.21

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).